Similarly, in osteosarcoma, TNF‐α‐loaded liposomes induced ICD in tumour cells, leading to TNF‐α‐triggered necrosis, tumour‐specific antigen release, enhanced DC activation, and T cell infiltration when combined with anti‐PD‐1/PD‐L1 therapy.125. Here, TNF is linked to osteosarcoma.